Beijing Kawin Technology Share-Holding Co., Ltd.
Quick facts
Phase 3 pipeline
- PEG-IFN-SA /RBV · Virology/Infectious Disease
PEG-IFN-SA is a pegylated interferon-alpha combined with ribavirin to stimulate antiviral immune responses and inhibit viral replication. - Pegasys /RBV · Virology/Hepatology
Pegasys (peginterferon alfa-2a) is an interferon that activates the immune system to fight viral infections, while ribavirin (RBV) is a nucleoside analog that inhibits viral replication.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: